Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    November 2018
  1. JACKSON GL, Smith VA, Edelman D, Woolson SL, et al
    Intermediate Diabetes Outcomes in Patients Managed by Physicians, Nurse Practitioners, or Physician Assistants: A Cohort Study.
    Ann Intern Med. 2018 Nov 20. pii: 2716077. doi: 10.7326/M17-1987.
    PubMed     Text format     Abstract available


  2. WHARAM JF, Lu CY, Zhang F, Callahan M, et al
    High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes.
    Ann Intern Med. 2018 Nov 20. pii: 2716078. doi: 10.7326/M17-3365.
    PubMed     Text format     Abstract available



  3. The Effect of High-Deductible Insurance Plans on Diabetes Care.
    Ann Intern Med. 2018 Nov 20. pii: 2716396. doi: 10.7326/P18-0018.
    PubMed     Text format    



  4. Comparing Diabetes Outcomes for Primary Care Provided by Physicians, Nurse Practitioners, and Physician Assistants.
    Ann Intern Med. 2018 Nov 20. pii: 2715823. doi: 10.7326/P18-0017.
    PubMed     Text format    


  5. TANNER M
    Risk scores overestimated risk for CVD in newly diagnosed type 2 diabetes.
    Ann Intern Med. 2018;169:JC59.
    PubMed     Text format    


    September 2018
  6. CENTOR RM, Barry MJ
    Web Exclusive. Annals On Call - Oral Pharmacologic Therapy in Type 2 Diabetes: Choosing Therapy Wisely.
    Ann Intern Med. 2018;169:OC1.
    PubMed     Text format    


  7. HUMPHREY LL, Kansagara D, Qaseem A
    World Health Organization Guidelines on Medicines for Diabetes Treatment Intensification: Commentary From the American College of Physicians High Value Care Committee.
    Ann Intern Med. 2018 Sep 4. pii: 2698899. doi: 10.7326/M18-1148.
    PubMed     Text format    


  8. ROGLIC G, Norris SL
    Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the
    Ann Intern Med. 2018 Sep 4. pii: 2698900. doi: 10.7326/M18-1149.
    PubMed     Text format     Abstract available


  9. CENTOR RM, Montori VM
    Web Exclusive. Annals On Call - Glycemic Control in Type 2 Diabetes: How Low Should We Go?
    Ann Intern Med. 2018;169:OC1.
    PubMed     Text format    


    August 2018

  10. Prevention of Diabetes With Mediterranean Diets.
    Ann Intern Med. 2018;169:271-272.
    PubMed     Text format    


  11. O'BRIEN R, Johnson E, Haneuse S, Coleman KJ, et al
    Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.
    Ann Intern Med. 2018 Aug 7. pii: 2696493. doi: 10.7326/M17-2383.
    PubMed     Text format     Abstract available



  12. Outcomes of Bariatric Surgery in Patients With Diabetes.
    Ann Intern Med. 2018 Aug 7:1. doi: 10.7326/P18-0012.
    PubMed     Text format    


    July 2018
  13. EGAN AM, Montori VM
    Review: In adults with type 1 diabetes, SGLT-2 inhibitors reduce HbA1c but increase diabetic ketoacidosis.
    Ann Intern Med. 2018;169:JC3.
    PubMed     Text format    


  14. EGAN AM, Montori VM
    Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors.
    Ann Intern Med. 2018;169:JC2.
    PubMed     Text format    


  15. MADENIDOU AV, Paschos P, Karagiannis T, Katsoula A, et al
    Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
    Ann Intern Med. 2018 Jul 10. pii: 2687651. doi: 10.7326/M18-0443.
    PubMed     Text format     Abstract available


    June 2018
  16. HIRSCH IB, Skyler JS
    Brief Commentary: Confusing Treatment Guidelines for Patients With Type 2 Diabetes.
    Ann Intern Med. 2018 Jun 26. pii: 2686099. doi: 10.7326/M18-1473.
    PubMed     Text format    


  17. SCHROEDER EB, Karter AJ
    Brief Commentary: Glycemic Targets for Older Adults With Type 2 Diabetes.
    Ann Intern Med. 2018 Jun 26. pii: 2686097. doi: 10.7326/M18-1471.
    PubMed     Text format    


  18. MILES DRB
    Brief Commentary: Social Determinants of Health and Treatment Targets for Type 2 Diabetes.
    Ann Intern Med. 2018 Jun 26. pii: 2686098. doi: 10.7326/M18-1472.
    PubMed     Text format    


  19. BURKE BV, Hedin S
    Brief Commentary: Laboratory Accuracy of Hemoglobin A1c Ranges and Treatment Targets for Patients With Type 2 Diabetes.
    Ann Intern Med. 2018 Jun 26. pii: 2686219. doi: 10.7326/M18-1482.
    PubMed     Text format    


  20. NARAYAN KMV, Jagannathan R
    Two in One: Diagnosing Type 2 Diabetes With Single-Sample Testing.
    Ann Intern Med. 2018 Jun 19. pii: 2685289. doi: 10.7326/M18-1477.
    PubMed     Text format    


  21. SELVIN E, Wang D, Lee AK, Coresh J, et al
    Identifying Trends in Undiagnosed Diabetes in U.S. Adults.
    Ann Intern Med. 2018;168:900-901.
    PubMed     Text format    


  22. PETERSEN MP, Cefalu WT
    Identifying Trends in Undiagnosed Diabetes in U.S. Adults.
    Ann Intern Med. 2018;168:900.
    PubMed     Text format    


  23. SELVIN E, Wang D, Matsushita K, Grams ME, et al
    Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study.
    Ann Intern Med. 2018 Jun 19. pii: 2684927. doi: 10.7326/M18-0091.
    PubMed     Text format     Abstract available


    May 2018
  24. MOIST L
    In type 2 diabetes with CVD and kidney disease, empagliflozin reduced mortality and hospitalization.
    Ann Intern Med. 2018;168:JC52.
    PubMed     Text format    


    April 2018
  25. BEKIARI E, Karagiannis T, Tsapas A
    In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER.
    Ann Intern Med. 2018;168:JC46.
    PubMed     Text format    


  26. VIGERSKY RA
    Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections.
    Ann Intern Med. 2018;168:528.
    PubMed     Text format    


  27. BECK RW, Riddlesworth TD
    Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections.
    Ann Intern Med. 2018;168:526-527.
    PubMed     Text format    


  28. HAAK T
    Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections.
    Ann Intern Med. 2018;168:525-526.
    PubMed     Text format    


  29. CHAMBERLAIN JJ, Johnson EL, Leal S, Rhinehart AS, et al
    Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
    Ann Intern Med. 2018 Apr 3. pii: 2677350. doi: 10.7326/M18-0222.
    PubMed     Text format     Abstract available


    March 2018
  30. GOEL A
    Intensive weight management in primary care improved weight loss and remission of type 2 diabetes.
    Ann Intern Med. 2018;168:JC30.
    PubMed     Text format    



  31. Hemoglobin A1c Targets for Nonpregnant Adults With Type 2 Diabetes Mellitus.
    Ann Intern Med. 2018 Mar 6. pii: 2674123. doi: 10.7326/P18-0003.
    PubMed     Text format    


  32. QASEEM A, Wilt TJ, Kansagara D, Horwitch C, et al
    Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.
    Ann Intern Med. 2018 Mar 6. pii: 2674121. doi: 10.7326/M17-0939.
    PubMed     Text format     Abstract available


    January 2018
  33. GENERE N, Montori VM
    Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas.
    Ann Intern Med. 2018;168:JC8.
    PubMed     Text format    


    December 2017
  34. LIPSCOMBE LL
    Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes.
    Ann Intern Med. 2017;167:JC67.
    PubMed     Text format    


  35. LIPSCOMBE LL
    Liraglutide reduced a composite renal outcome at a median 4 y in patients with type 2 diabetes and high CV risk.
    Ann Intern Med. 2017;167:JC66.
    PubMed     Text format    



  36. Cost-Effectiveness of Individualized Management of Diabetes Among U.S. Adults.
    Ann Intern Med. 2017 Dec 12. pii: 2665905. doi: 10.7326/P17-9050.
    PubMed     Text format    


  37. LAITEERAPONG N, Cooper JM, Skandari MR, Clarke PM, et al
    Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis.
    Ann Intern Med. 2017 Dec 12. pii: 2665902. doi: 10.7326/M17-0537.
    PubMed     Text format     Abstract available


    October 2017
  38. SELVIN E, Wang D, Lee AK, Bergenstal RM, et al
    Identifying Trends in Undiagnosed Diabetes in U.S. Adults by Using a Confirmatory Definition: A Cross-sectional Study.
    Ann Intern Med. 2017 Oct 24. doi: 10.7326/M17-1272.
    PubMed     Text format     Abstract available


  39. CONLIN PR, Colburn J, Aron D, Pries RM, et al
    Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus.
    Ann Intern Med. 2017 Oct 24. doi: 10.7326/M17-1362.
    PubMed     Text format     Abstract available


  40. PETERS AL
    Rethinking Rates of Undiagnosed Diabetes: The Value of a Confirmatory Test.
    Ann Intern Med. 2017 Oct 24. doi: 10.7326/M17-2576.
    PubMed     Text format    


  41. DASGUPTA I, Singh AK
    Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death.
    Ann Intern Med. 2017;167:JC47.
    PubMed     Text format    


  42. MURFF HJ
    Self-monitoring of blood glucose did not improve HbA1c or QoL at 1 year in non-insulin-treated type 2 diabetes.
    Ann Intern Med. 2017;167:JC46.
    PubMed     Text format    


    September 2017
  43. CHAMBERLAIN JJ, Kalyani RR, Leal S, Rhinehart AS, et al
    Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.
    Ann Intern Med. 2017 Sep 12. doi: 10.7326/M17-1259.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: